GOP Continuing Resolution Would Fund FDA At 2024 Levels

Democrats are raising concerns that the continuing resolution intended to fund the government for the remainder of fiscal year 2025 gives Trump too much power, though it is unclear whether the FDA would be as impacted as other agencies.

US Capitol at sunset.
Congress narrowly avoided a government shutdown, but pharma priorities were shutout. (Shutterstock)
Key Takeaways
  • The FDA budget would remain at the FY 2024 level under a Republican spending bill to fund the government for the remainder of FY 2025, marking two straight years with no taxpayer funding boost.
  • The continuing resolution also does not address other policies that were dropped from Congress' 2024 year-end spending bill.
  • Democrats oppose the CR because it transfers too much power to the Trump Administration, meaning a government shutdown is possible.

The US Food and Drug Administration would see its second straight year without a boost in taxpayer funds under a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medtech Insight

More from Legislation